Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer
Jane Blazeby(Royal College of Surgeons of England), Derek Alderson(University of Bristol), Peter Fayers(University of Aberdeen), Orhan Sezer(Charité - Universitätsmedizin Berlin), Pierre-Luc Etienne, Eva Hammerlid(Sahlgrenska University Hospital), Michael Koller(University Hospital Regensburg), Andrew Bottomley(European Organisation for Research and Treatment of Cancer), Juan Ignacio Arrarás, C W Vickery(University of Bristol), Thierry Conroy(Inserm)
Cited by 415
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
EORTC QLQ-C30 Scoring Manual
|Research at the University of Copenhagen (University of Copenhagen)|1995|2.4k
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
|Journal of Clinical Oncology|2011|2.1k
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
|Journal of Clinical Oncology|2006|1.7k